A recent scientific study has revealed promising early findings suggesting that high doses of vitamin B3, known as niacin, may help enhance treatment effectiveness in patients with glioblastoma, one of the most aggressive and rapidly progressing forms of brain cancer.
According to the study conducted by researchers at the University of Calgary, adding niacin to standard treatment protocols, including surgery, radiotherapy, and chemotherapy, helped halt disease progression in up to 82% of patients over six months, compared to approximately 54% among those who received standard treatment without the supplement.
Researchers suggest that niacin may play a role in strengthening the immune system by supporting and reactivating immune cells, thereby improving their ability to identify and attack cancer cells, potentially helping to slow tumor growth.
Despite these encouraging results, experts emphasize that the study is still in its early stages, involving a limited number of participants, a short follow-up period, and no large randomized controlled design, highlighting the need for further extensive clinical trials to validate the findings.
Doctors also caution against using high doses of vitamins without medical supervision due to possible side effects, stressing that niacin should not be considered a standalone treatment but rather a potential supportive component within a comprehensive treatment approach under investigation.
Researchers hope these findings will pave the way for larger and more comprehensive clinical studies in the future to better assess safety and efficacy, and to explore the possibility of integrating this approach into brain cancer treatment protocols.
For more news and reports, follow Egypt Connect
